drugset / Trial / NCT02296294

Body Composition Monitoring for Determination of the Fluid Status in Volunteers Undergoing Intravenous Fluid Therapy

NCT02296294 ↗

Completed 15 enrolled Medical University of Vienna
RandomizedCrossoverSingle-blindDiagnostic

Summary

This volunteer study tests a recently developed whole-body bioimpedance spectroscopy device called Body Composition Monitor (BCM) which measures the body composition (i.e. the water content of the body). Specifically, the investigators will evaluate the use of BCM for correct detection of intravenous administered crystalloids in the volunteers´ fluid compartments. Furthermore we will test the change over time of the volunteers´ volume status after an intravenous fluid therapy.

Timeline

Start
2014-10
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Elo-mel® Unknown — Intravenous

Indications

No indication recorded.